Table of Contents
<< Previous Issue | Aug 2017 (Vol: 2017, Issue: 8) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Bristol-Myers Squibb Fights Immuno-oncology Competition with Early stage Biotech Acquisition
-
Mitsubishi Pharma Acquires NeuroDerm for Parkinson’s Drug
-
Gilead Acquires CAR-T Oncology Specialist Kite for US$11.9 B
- Section: Opinion & Analysis
-
IMS PharmaDeals: Half-Year Review of 2017
- Section: Research & Development
-
AstraZeneca Signs Massive US$8.5 B Oncology Collaboration with Merck & Co Following Trial Failure